MKI67 and metastatic malignant neoplasm in the lymph nodes: A higher median of Ki-67 LI is significantly observed in unencapsulated tumors (median = 2.75, p = 0.024), advanced (III-IV) clinical stage (median = 5.6, p = 0.015), aggressive subtype (median = 3.47, p < 0.001), tall cells subtype (median = 4, p < 0.001), lymph node metastasis (median = 2.85, p = 0.008), distant/organ metastasis (median = 4.45, p = 0.014), LVI (median = 3.45, p < 0.001), ETE (median = 3.4, p < 0.001), and BRAFV600E (median = 2.92, p = 0.021).